Provenge, despite its demonstrated survival advantage, continues to be knocked as a viable treatment for men with castrate-resistant prostate cancer.

What is Provenge?

Provenge is immunotherapy for men with metastatic castrate-resistant prostate cancer. In other words, Provenge might help men live longer after their cancer has spread outside of the prostate and are no longer responding to androgen deprivation therapy (ADT).

Provenge is a personalized, tailored-for-you therapy made with your own cells. Even though Provenge is created using your own blood, it is not going to help all men with metastatic castrate-resistant prostate cancer.

Will Provenge lower my PSA?

Provenge does not lower PSA. In fact, many men will continue to see their PSA rise, as well as their prostate cancer progress, based on scans. With the emphasis on PSA prior to becoming metastatic, it’s easy to feel worried or skeptical regarding Provenge if don’t see a drop in your PSA during Provenge therapy.